CompanyGraph
What stands out
- Most companies in its industry are production businesses; this one is a flow business
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- ScaleMarket cap is $1.48B, above the global median of $1.15B
- PositionCurrent ratio is 0.93×, lower than 95% of its Medical Devices peers (median 2.76×)
- Interpretations3 currently firing — 3
What this company is and how it runs — written from structure, not news.
What stands out
- Most companies in its industry are production businesses; this one is a flow business
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.48BUSDvs all stocks (USD)
Revenue (TTM)
3.29BUSDvs all stocks (USD)
Profit Margin
-2.42%vs Medical Devices peers
Beta
1.45xvs all stocks
52-Week Change
18.33%vs all stocks
Market Capitalization
1.48BUSDvs all stocks (USD)
Enterprise Value
3.37BUSDvs all stocks (USD)
Forward P/E
9.02xvs Medical Devices peers
Price to Sales (TTM)
0.4384xvs Medical Devices peers
Price to Book (MRQ)
0.9351xvs Medical Devices peers
Enterprise to Revenue
1.02xvs Medical Devices peers
Enterprise to EBITDA
5.78xvs Medical Devices peers
Profit Margin
-2.42%vs Medical Devices peers
Operating Margin
0.67%vs Medical Devices peers
Return on Assets (TTM)
2.64%vs Medical Devices peers
Return on Equity (TTM)
-4.85%vs Medical Devices peers
Revenue (TTM)
3.29BUSDvs all stocks (USD)
Revenue per Share (TTM)
24.28USDUpdated Jul 17, 2026Quarterly Revenue Growth
5.40%vs Medical Devices peers
Gross Profit (TTM)
670.35MUSDvs all stocks (USD)
EBITDA (TTM)
547.56MUSDvs all stocks (USD)
Net Income (TTM)
-79.63MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
5.83%vs Medical Devices peers
Operating Cash Flow (TTM)
599.97MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
267.90MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 17, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Devices peers
Minority Interest (Equity)
7.76MUSDFY2025 · Dec 31, 2025Revenue
3.24BUSDFY2025 · Dec 31, 2025Cost of Goods Sold
2.64BUSDFY2025 · Dec 31, 2025Gross Profit
609.20MUSDFY2025 · Dec 31, 2025Operating Income
186.27MUSDvs all stocks (USD)
Pre-tax Income
-15.15MUSDFY2025 · Dec 31, 2025Income Tax Expense
50.88MUSDFY2025 · Dec 31, 2025Net Income
-66.04MUSDFY2025 · Dec 31, 2025EBIT
90.60MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
567.92MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
382.29MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
105.75MUSDFY2025 · Dec 31, 2025EPS (Basic)
-0.5200USDFY2025 · Dec 31, 2025EPS (Diluted)
-0.5200USDFY2025 · Dec 31, 2025Basic Shares Outstanding
135.15MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
135.15MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-66.04MUSDFY2025 · Dec 31, 2025Minority Interests (P&L)
-4.76MUSDFY2025 · Dec 31, 2025Operating Cash Flow
567.45MUSDFY2025 · Dec 31, 2025Free Cash Flow
185.06MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
106.14MUSDFY2025 · Dec 31, 2025Income Tax Paid
24.28MUSDFY2025 · Dec 31, 2025Interest Paid
101.24MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-66.04MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
381.93MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
47.16MUSDFY2025 · Dec 31, 2025Stock-based Compensation
21.88MUSDFY2025 · Dec 31, 2025Other Non-cash Items
54.87MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
30.99MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
96.66MUSDFY2025 · Dec 31, 2025Capital Expenditures
-382.39MUSDFY2025 · Dec 31, 2025Net Acquisitions
78.04MUSDFY2025 · Dec 31, 2025Purchase of Investments
0.00USDFY2025 · Dec 31, 2025Other Investing Activity
1.16MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-303.19MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025Long-term Debt Payments
-268.48MUSDFY2025 · Dec 31, 2025Common Stock Repurchase
0.00USDFY2025 · Dec 31, 2025Other Financing Charges
-34.92MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-303.40MUSDFY2025 · Dec 31, 2025Shares Outstanding
133.08MSharesUpdated Jul 17, 2026Float Shares
85.56MSharesUpdated Jul 17, 2026Shares Short
8.06MSharesUpdated Jul 17, 2026Short Ratio
4.86daysvs all stocks
Short % of Shares Outstanding
7.83%vs all stocks
% Held by Insiders
8.14%vs all stocks
% Held by Institutions
106.71%vs all stocks
Total Cash (MRQ)
47.96MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
0.3600USDUpdated Jul 17, 2026Total Debt (MRQ)
2.00BUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
1.32xvs Medical Devices peers
Current Ratio (MRQ)
0.9250xvs Medical Devices peers
Book Value per Share (MRQ)
11.32USDUpdated Jul 17, 2026Total Assets
4.32BUSDvs all stocks (USD)
Total Current Assets
728.90MUSDFY2025 · Dec 31, 2025Total Liabilities
2.79BUSDFY2025 · Dec 31, 2025Total Non-current Assets
3.59BUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
2.08BUSDFY2025 · Dec 31, 2025Total Current Liabilities
712.39MUSDFY2025 · Dec 31, 2025Cash
106.14MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
106.14MUSDFY2025 · Dec 31, 2025Accounts Receivable
370.90MUSDFY2025 · Dec 31, 2025Inventory
151.25MUSDFY2025 · Dec 31, 2025Accounts Payable
352.38MUSDFY2025 · Dec 31, 2025Short-term Debt
68.74MUSDFY2025 · Dec 31, 2025Deferred Revenue
59.84MUSDFY2025 · Dec 31, 2025Other Current Liabilities
30.11MUSDFY2025 · Dec 31, 2025Long-term Debt
1.83BUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
243.80MUSDFY2025 · Dec 31, 2025Common Stock (Book)
13.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-632.97MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
1.53BUSDvs all stocks (USD)
Treasury Stock
25.55MUSDFY2025 · Dec 31, 202552-Week Low
8.51USDUpdated Jul 17, 202652-Week High
13.43USDUpdated Jul 17, 202652-Week Change
18.33%vs all stocks
Beta
1.45xvs all stocks
50-Day MA
10.38USDUpdated Jul 17, 2026200-Day MA
10.29USDUpdated Jul 17, 2026Avg 10-Day Volume
1.09MSharesUpdated Jul 17, 2026Avg 30-Day Volume
1.46MSharesUpdated Jul 17, 2026Diluted EPS (TTM)
-0.6100USDUpdated Jul 17, 2026Other Income / Expense
-95.67MUSDFY2025 · Dec 31, 20253 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Decline With Range Expansion And Drawdown
The price is falling, swinging wider than usual, and sits well below its peak.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
Sharp Decline With Volume And Volatility Expansion
A steep fall on heavy volume, leaving the price far below its peak.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Current ratio is 0.93×, lower than 95% of its Medical Devices peers (median 2.76×)Significant
Current ratio: 0.93Industry median: 2.76Industry P5: 1.18Peers compared: 59.00
Price-to-book is 0.94×, lower than 95% of its Medical Devices peers (median 3.08×)Notable
Price-to-book: 0.94Industry median: 3.08Industry P5: 1.04Peers compared: 59.00
Structural Tensions
Most companies in its industry are production businesses; this one is a flow businessSignificant
Industry peers: 174Share on the common pattern %: 98.00
Financial Health
Altman Z-Score 0.94: distress zoneCritical
Altman Z-Score: 0.94
High earnings qualityNotable
Earnings Quality Score: 3.20
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Scale
Market cap is $1.48B, above the global median of $1.15BNotable
Market cap (USD): 1,482,990,256Global Median: 1,146,734,693.424
Revenue is $3.29B, above the global median of $520.53MNotable
Revenue (USD): 3,286,774,016Global Median: 520,528,949.311
Levered free cash flow is $267.9M, above the global median of $16.24MNotable
Levered free cash flow (USD): 267,899,632Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Iridium Corporation
Tier 1FlowApproval-Gated PipelineProduction
Hyundai Movex Co., Ltd.
Tier 1FlowApproval-Gated PipelineProductionRisk
Lumexa Imaging Holdings, Inc.
Tier 1FlowApproval-Gated PipelineInterfaceRule
Nanjing Pharmaceutical Co., Ltd.
Tier 1FlowApproval-Gated PipelineInterfaceRule
Viemed Healthcare Inc.
Tier 1FlowApproval-Gated PipelineProductionRule
Dimed S.A. Distribuidora de Medicamentos
Tier 1FlowApproval-Gated PipelineInterfaceRule
Com7 Public Company Limited
Tier 3FlowUnit ReplicationInterfaceAttention
Xinjiang Tianfu Energy Co., Ltd.
Tier 3FlowRegulated Return InfrastructureProductionRisk
Alliant Energy Corporation
Tier 3FlowThroughput-Bound ConversionProductionRule
Dicker Data Limited
Tier 3FlowThroughput-Bound ConversionRiskInterface
Companies that share active interpretations — structural patterns currently present in both stocks.
Wintao Communications Co.
3 interpretationsDecline With Range Expansion And DrawdownUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedSharp Decline With Volume And Volatility Expansion
Hertz Global Holdings, Inc.
3 interpretationsDecline With Range Expansion And DrawdownUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedSharp Decline With Volume And Volatility Expansion
TaskUs, Inc.
3 interpretationsDecline With Range Expansion And DrawdownUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedSharp Decline With Volume And Volatility Expansion